首页 > 最新文献

Yonago acta medica最新文献

英文 中文
Image Quality and Lesion Detection of Multiplanar Reconstruction Images Using Deep Learning: Comparison with Hybrid Iterative Reconstruction. 使用深度学习的多平面重建图像的图像质量和病灶检测:与混合迭代重建的比较
IF 1 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-04-22 eCollection Date: 2024-05-01 DOI: 10.33160/yam.2024.05.001
Hiroto Yunaga, Hidenao Miyoshi, Ryoya Ochiai, Takuro Gonda, Toshio Sakoh, Hisashi Noma, Shinya Fujii

Background: We assessed and compared the image quality of normal and pathologic structures as well as the image noise in chest computed tomography images using "adaptive statistical iterative reconstruction-V" (ASiR-V) or deep learning reconstruction "TrueFidelity".

Methods: Forty consecutive patients with suspected lung disease were evaluated. The 1.25-mm axial images and 2.0-mm coronal multiplanar images were reconstructed under the following three conditions: (i) ASiR-V, lung kernel with 60% of ASiR-V; (ii) TF-M, standard kernel, image filter (Lung) with TrueFidelity at medium strength; and (iii) TF-H, standard kernel, image filter (Lung) with TrueFidelity at high strength. Two radiologists (readers) independently evaluated the image quality of anatomic structures using a scale ranging from 1 (best) to 5 (worst). In addition, readers ranked their image preference. Objective image noise was measured using a circular region of interest in the lung parenchyma. Subjective image quality scores, total scores for normal and abnormal structures, and lesion detection were compared using Wilcoxon's signed-rank test. Objective image quality was compared using Student's paired t-test and Wilcoxon's signed-rank test. The Bonferroni correction was applied to the P value, and significance was assumed only for values of P < 0.016.

Results: Both readers rated TF-M and TF-H images significantly better than ASiR-V images in terms of visualization of the centrilobular region in axial images. The preference score of TF-M and TF-H images for reader 1 were better than that of ASiR-V images, and the preference score of TF-H images for reader 2 were significantly better than that of ASiR-V and TF-M images. TF-M images showed significantly lower objective image noise than ASiR-V or TF-H images.

Conclusion: TrueFidelity showed better image quality, especially in the centrilobular region, than ASiR-V in subjective and objective evaluations. In addition, the image texture preference for TrueFidelity was better than that for ASiR-V.

背景我们评估并比较了使用 "自适应统计迭代重建-V"(ASiR-V)或深度学习重建 "TrueFidelity "的胸部计算机断层扫描图像中正常和病理结构的图像质量以及图像噪声:方法: 对 40 名疑似肺部疾病的连续患者进行了评估。在以下三种条件下对 1.25 毫米轴向图像和 2.0 毫米冠状多平面图像进行了重建:(i) ASiR-V,60% ASiR-V 的肺部内核;(ii) TF-M,标准内核,中等强度 TrueFidelity 图像滤波器(肺部);(iii) TF-H,标准内核,高强度 TrueFidelity 图像滤波器(肺部)。两名放射科医生(阅读者)使用从 1(最佳)到 5(最差)的量表独立评估解剖结构的图像质量。此外,读者还对自己的图像偏好进行了排序。客观图像噪声使用肺实质中的圆形感兴趣区进行测量。采用 Wilcoxon 符号秩检验比较主观图像质量得分、正常和异常结构总分以及病变检测。客观图像质量采用学生配对 t 检验和 Wilcoxon 符号秩检验进行比较。对 P 值进行 Bonferroni 校正,仅当 P 值小于 0.016 时才假定显著性:两位读者对 TF-M 和 TF-H 图像在轴向图像中中央叶区可视化方面的评分均明显优于 ASiR-V 图像。读者 1 对 TF-M 和 TF-H 图像的偏好评分优于 ASiR-V 图像,读者 2 对 TF-H 图像的偏好评分明显优于 ASiR-V 和 TF-M 图像。TF-M 图像的客观图像噪声明显低于 ASiR-V 或 TF-H 图像:结论:在主观和客观评价方面,TrueFidelity 的图像质量(尤其是在中央叶区)均优于 ASiR-V。此外,TrueFidelity 对图像纹理的偏好也优于 ASiR-V。
{"title":"Image Quality and Lesion Detection of Multiplanar Reconstruction Images Using Deep Learning: Comparison with Hybrid Iterative Reconstruction.","authors":"Hiroto Yunaga, Hidenao Miyoshi, Ryoya Ochiai, Takuro Gonda, Toshio Sakoh, Hisashi Noma, Shinya Fujii","doi":"10.33160/yam.2024.05.001","DOIUrl":"10.33160/yam.2024.05.001","url":null,"abstract":"<p><strong>Background: </strong>We assessed and compared the image quality of normal and pathologic structures as well as the image noise in chest computed tomography images using \"adaptive statistical iterative reconstruction-V\" (ASiR-V) or deep learning reconstruction \"TrueFidelity\".</p><p><strong>Methods: </strong>Forty consecutive patients with suspected lung disease were evaluated. The 1.25-mm axial images and 2.0-mm coronal multiplanar images were reconstructed under the following three conditions: (i) ASiR-V, lung kernel with 60% of ASiR-V; (ii) TF-M, standard kernel, image filter (Lung) with TrueFidelity at medium strength; and (iii) TF-H, standard kernel, image filter (Lung) with TrueFidelity at high strength. Two radiologists (readers) independently evaluated the image quality of anatomic structures using a scale ranging from 1 (best) to 5 (worst). In addition, readers ranked their image preference. Objective image noise was measured using a circular region of interest in the lung parenchyma. Subjective image quality scores, total scores for normal and abnormal structures, and lesion detection were compared using Wilcoxon's signed-rank test. Objective image quality was compared using Student's paired <i>t</i>-test and Wilcoxon's signed-rank test. The Bonferroni correction was applied to the P value, and significance was assumed only for values of <i>P</i> < 0.016.</p><p><strong>Results: </strong>Both readers rated TF-M and TF-H images significantly better than ASiR-V images in terms of visualization of the centrilobular region in axial images. The preference score of TF-M and TF-H images for reader 1 were better than that of ASiR-V images, and the preference score of TF-H images for reader 2 were significantly better than that of ASiR-V and TF-M images. TF-M images showed significantly lower objective image noise than ASiR-V or TF-H images.</p><p><strong>Conclusion: </strong>TrueFidelity showed better image quality, especially in the centrilobular region, than ASiR-V in subjective and objective evaluations. In addition, the image texture preference for TrueFidelity was better than that for ASiR-V.</p>","PeriodicalId":23795,"journal":{"name":"Yonago acta medica","volume":"67 2","pages":"100-107"},"PeriodicalIF":1.0,"publicationDate":"2024-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11128077/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141158838","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy, Safety, and Continuation of Biological Therapy in Older Patients with Asthma in a Real-World Setting: A Retrospective Observational Study. 在真实世界环境中对老年哮喘患者使用生物疗法的疗效、安全性和持续性:回顾性观察研究
IF 1 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-04-22 eCollection Date: 2024-05-01 DOI: 10.33160/yam.2024.05.003
Ryota Okazaki, Tomoya Harada, Yoshihiro Funaki, Masato Morita, Miki Takata, Hiroki Kohno, Hiroki Ishikawa, Genki Inui, Miyu Nishigami, Mitsuhiro Yamamoto, Aditya Sri Listyoko, Akira Yamasaki

Background: Major randomized clinical trials have shown that biological therapy can reduce the exacerbation rate and oral corticosteroid (OCS) dosage in patients with severe eosinophilic asthma. However, data on the continuation, efficacy, and safety of biological therapy in older patients with asthma are limited. Therefore, the aim of this study was to evaluate the differences in the continuation rate, efficacy, and safety of biological therapy between older (≥ 65 years) and younger (< 65 years) patients with asthma.

Methods: In this single-center retrospective observational study, we collected clinical data of patients with asthma who were administered biological drugs such as omalizumab, mepolizumab, benralizumab, and dupilumab between April 2009 and August 2022. We comparatively analyzed the continuation, efficacy, and safety of biological therapy between older (age ≥ 65 years) and younger patient (age < 65 years) groups. The reasons for discontinuation or switching of biological drugs were also evaluated.

Results: Sixty-two (31 older and 31 younger) patients were treated with 91 biologics during the observational period. The mean age of older patients was 74.3 ± 5.1 years and that of younger patients was 48.0 ± 14.0 years. The continuation rate of biological therapy was not significantly different between the groups. Social background was the most common reason for discontinuation of biological therapy in both groups, and insufficient effect was the most common reason for switching to biological drugs. Asthma exacerbations decreased in both groups within the first 12 months of biologic therapy. The dosage of OCS tended to decrease in the older group and significantly decrease in the younger group.

Conclusion: Biologic therapy for older patients with asthma can be continued, with efficacy and safety similar to those in younger patients with asthma.

背景:主要的随机临床试验表明,生物疗法可以降低严重嗜酸性粒细胞性哮喘患者的病情恶化率和口服皮质类固醇(OCS)的用量。然而,有关生物疗法在老年哮喘患者中的持续性、有效性和安全性的数据却很有限。因此,本研究旨在评估老年(≥ 65 岁)和年轻(< 65 岁)哮喘患者在生物疗法的持续率、疗效和安全性方面的差异:在这项单中心回顾性观察研究中,我们收集了 2009 年 4 月至 2022 年 8 月期间使用奥马珠单抗、美博利珠单抗、苯拉珠单抗和杜匹单抗等生物药物的哮喘患者的临床数据。我们比较分析了老年组(年龄≥ 65 岁)和年轻组(年龄< 65 岁)患者继续使用生物疗法的情况、疗效和安全性。我们还评估了停用或更换生物药物的原因:在观察期间,62 名患者(31 名老年患者和 31 名年轻患者)接受了 91 种生物制剂的治疗。老年患者的平均年龄为(74.3 ± 5.1)岁,年轻患者的平均年龄为(48.0 ± 14.0)岁。两组患者继续接受生物制剂治疗的比例无明显差异。社会背景是两组患者停止生物治疗的最常见原因,而疗效不佳是转用生物药物的最常见原因。两组患者在接受生物治疗的头 12 个月内,哮喘加重的情况都有所减少。老年组患者的OCS用量趋于减少,而年轻组患者的OCS用量则明显减少:结论:老年哮喘患者可以继续接受生物制剂治疗,其疗效和安全性与年轻哮喘患者相似。
{"title":"Efficacy, Safety, and Continuation of Biological Therapy in Older Patients with Asthma in a Real-World Setting: A Retrospective Observational Study.","authors":"Ryota Okazaki, Tomoya Harada, Yoshihiro Funaki, Masato Morita, Miki Takata, Hiroki Kohno, Hiroki Ishikawa, Genki Inui, Miyu Nishigami, Mitsuhiro Yamamoto, Aditya Sri Listyoko, Akira Yamasaki","doi":"10.33160/yam.2024.05.003","DOIUrl":"10.33160/yam.2024.05.003","url":null,"abstract":"<p><strong>Background: </strong>Major randomized clinical trials have shown that biological therapy can reduce the exacerbation rate and oral corticosteroid (OCS) dosage in patients with severe eosinophilic asthma. However, data on the continuation, efficacy, and safety of biological therapy in older patients with asthma are limited. Therefore, the aim of this study was to evaluate the differences in the continuation rate, efficacy, and safety of biological therapy between older (≥ 65 years) and younger (< 65 years) patients with asthma.</p><p><strong>Methods: </strong>In this single-center retrospective observational study, we collected clinical data of patients with asthma who were administered biological drugs such as omalizumab, mepolizumab, benralizumab, and dupilumab between April 2009 and August 2022. We comparatively analyzed the continuation, efficacy, and safety of biological therapy between older (age ≥ 65 years) and younger patient (age < 65 years) groups. The reasons for discontinuation or switching of biological drugs were also evaluated.</p><p><strong>Results: </strong>Sixty-two (31 older and 31 younger) patients were treated with 91 biologics during the observational period. The mean age of older patients was 74.3 ± 5.1 years and that of younger patients was 48.0 ± 14.0 years. The continuation rate of biological therapy was not significantly different between the groups. Social background was the most common reason for discontinuation of biological therapy in both groups, and insufficient effect was the most common reason for switching to biological drugs. Asthma exacerbations decreased in both groups within the first 12 months of biologic therapy. The dosage of OCS tended to decrease in the older group and significantly decrease in the younger group.</p><p><strong>Conclusion: </strong>Biologic therapy for older patients with asthma can be continued, with efficacy and safety similar to those in younger patients with asthma.</p>","PeriodicalId":23795,"journal":{"name":"Yonago acta medica","volume":"67 2","pages":"114-123"},"PeriodicalIF":1.0,"publicationDate":"2024-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11128083/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141158827","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Combination Biologic Therapy with Mepolizumab and Dupilumab for Severe Eosinophilic Granulomatosis with Polyangiitis and Chronic Rhinosinusitis with Nasal Polyp. 用美泊利单抗和杜匹单抗联合生物疗法治疗严重嗜酸性粒细胞增多性多发性炎和慢性鼻窦炎伴鼻息肉。
IF 1 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-04-17 eCollection Date: 2024-05-01 DOI: 10.33160/yam.2024.05.005
Yosuke Nakamura, Naoki Kikumoto, Hiromi Takeuchi, Toru Kimura, Motoki Nakamori, Kazunori Fujiwara

We report the case of a 55-year-old female with eosinophilic granulomatosis with polyangiitis and chronic rhinosinusitis with nasal polyp. Rhinosinusitis recurred 6 months after full-house endoscopic sinus surgery. Although conventional treatment with azathioprine and mepolizumab with steroids was given, it was difficult to simultaneously control both rhinosinusitis and eosinophilic granulomatosis with polyangiitis. Clinical examinations showed polyps in the olfactory cleft, and the patient's anosmia gradually became persistent. Even after administering mepolizumab for a certain period of time, symptoms did not improve, but when the biologic agent was switched to dupilumab, an improvement in recalcitrant chronic rhinosinusitis with nasal polyp was observed. While dupilumab was administered intermittently for refractory chronic rhinosinusitis with nasal polyp, the rhinosinusitis improved and symptoms such as worsening of eosinophilic granulomatosis with polyangiitis paresthesia were observed. Both symptoms gradually subsided 19 months after starting intermittent administration, leading to the discontinuation of dupilumab administration. Rhinosinusitis in the setting of eosinophilic granulomatosis with polyangiitis may be refractory in some cases, and this case provides findings demonstrating the strong effect of dupilumab on eosinophilic inflammation.

我们报告了一例 55 岁女性患者的病例,她患有嗜酸性粒细胞肉芽肿伴多血管炎和伴有鼻息肉的慢性鼻窦炎。鼻窦炎在全鼻腔内窥镜鼻窦手术后 6 个月复发。虽然采用了硫唑嘌呤和甲泼尼龙联合类固醇的常规治疗,但很难同时控制鼻炎和嗜酸性肉芽肿伴多血管炎。临床检查显示患者的嗅裂有息肉,而且患者的嗅觉障碍逐渐变得顽固。即使使用了一段时间的美泊珠单抗,症状也没有得到改善,但当生物制剂换成杜比鲁单抗后,顽固性慢性鼻窦炎伴鼻息肉的症状得到了改善。在对难治性慢性鼻炎伴鼻息肉患者间歇性使用杜必鲁单抗时,鼻炎得到了改善,但嗜酸性粒细胞肉芽肿伴多血管炎麻痹等症状也有所加重。这两种症状在开始间歇用药 19 个月后逐渐缓解,因此停用了杜比鲁单抗。嗜酸性粒细胞肉芽肿伴多血管炎引起的鼻窦炎在某些病例中可能是难治性的,本病例的研究结果表明了杜必鲁单抗对嗜酸性粒细胞炎症的强大疗效。
{"title":"Combination Biologic Therapy with Mepolizumab and Dupilumab for Severe Eosinophilic Granulomatosis with Polyangiitis and Chronic Rhinosinusitis with Nasal Polyp.","authors":"Yosuke Nakamura, Naoki Kikumoto, Hiromi Takeuchi, Toru Kimura, Motoki Nakamori, Kazunori Fujiwara","doi":"10.33160/yam.2024.05.005","DOIUrl":"10.33160/yam.2024.05.005","url":null,"abstract":"<p><p>We report the case of a 55-year-old female with eosinophilic granulomatosis with polyangiitis and chronic rhinosinusitis with nasal polyp. Rhinosinusitis recurred 6 months after full-house endoscopic sinus surgery. Although conventional treatment with azathioprine and mepolizumab with steroids was given, it was difficult to simultaneously control both rhinosinusitis and eosinophilic granulomatosis with polyangiitis. Clinical examinations showed polyps in the olfactory cleft, and the patient's anosmia gradually became persistent. Even after administering mepolizumab for a certain period of time, symptoms did not improve, but when the biologic agent was switched to dupilumab, an improvement in recalcitrant chronic rhinosinusitis with nasal polyp was observed. While dupilumab was administered intermittently for refractory chronic rhinosinusitis with nasal polyp, the rhinosinusitis improved and symptoms such as worsening of eosinophilic granulomatosis with polyangiitis paresthesia were observed. Both symptoms gradually subsided 19 months after starting intermittent administration, leading to the discontinuation of dupilumab administration. Rhinosinusitis in the setting of eosinophilic granulomatosis with polyangiitis may be refractory in some cases, and this case provides findings demonstrating the strong effect of dupilumab on eosinophilic inflammation.</p>","PeriodicalId":23795,"journal":{"name":"Yonago acta medica","volume":"67 2","pages":"157-162"},"PeriodicalIF":1.0,"publicationDate":"2024-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11128079/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141158853","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Impact of Simulation-Based Training on Self-Efficacy in Sedation for Pediatric Magnetic Resonance Imaging. 模拟训练对小儿磁共振成像镇静自我效能的影响。
IF 1 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-04-17 eCollection Date: 2024-05-01 DOI: 10.33160/yam.2024.05.002
Yuto Arai, Kento Ohta, Go Yoshino, Tohru Okanishi, Yoshihiro Maegaki

Background: In Japan, approximately 35% of facilities experience sedation-related complications for pediatric magnetic resonance imaging (MRI), including severe complications such as respiratory and cardiac arrests. In the medical education field, simulation improves not only the quality of real emergency response but also health care workers' self-efficacy. Individuals with high self-efficacy are better prepared at handling diverse conditions. However, there is no research examining the impact of sedation simulation for pediatric MRI on the self-efficacy of health care workers. This study aimed to retrospectively investigate the impact of sedation simulation for pediatric MRI on the self-efficacy of health care workers in sedation.

Methods: The study was conducted on August 18, 2023, and enrolled pediatricians, nurses, and radiological technologists. The impact of sedation simulation for pediatric MRI on the participants was analyzed using confidence scale scores and part of the Pediatric Resuscitation and Escalation of Care Self-Efficacy Scale (PRSES), before and after sedation simulation for pediatric MRI.

Results: Eighteen participants (six pediatricians, six nurses, and six radiological technologists) were included in this study. Regarding confidence scale scores, a significant improvement was observed in the overall group (P = 0.002) and among the nurses (P = 0.0036). Regarding the item 'When confronted with a clinically deteriorating child, I know how to ask for assistance' of PRSES, a significant improvement was observed in the overall group (P = 0.0035) and among the radiological technologists (P = 0.048).

Conclusion: There's a potential for sedation simulation for pediatric MRI to increase the self-efficacy of health care workers in MRI sedation. Our findings suggest that this training has a valuable role in preparing health care workers to practice sedation for pediatric MRI.

背景:在日本,约有 35% 的机构在进行小儿磁共振成像(MRI)时出现镇静相关并发症,包括呼吸和心跳骤停等严重并发症。在医学教育领域,模拟不仅能提高真实应急反应的质量,还能提高医护人员的自我效能。自我效能感高的人在处理各种情况时准备得更充分。然而,目前还没有研究探讨儿科磁共振成像镇静模拟对医护人员自我效能的影响。本研究旨在回顾性调查儿科磁共振成像镇静模拟对医护人员镇静自我效能的影响:该研究于 2023 年 8 月 18 日进行,招募了儿科医生、护士和放射技师。结果:18 名参与者(6 名儿科医生、1 名护士和 1 名放射技师)在儿科磁共振成像镇静模拟之前和之后,使用信心量表评分和部分儿科复苏和护理升级自我效能量表(PRSES)分析了儿科磁共振成像镇静模拟对参与者的影响:本研究共纳入了 18 名参与者(6 名儿科医生、6 名护士和 6 名放射技术人员)。在自信量表得分方面,观察到整个小组(P = 0.002)和护士(P = 0.0036)都有显著提高。关于 PRSES 中的 "当遇到临床病情恶化的患儿时,我知道如何寻求帮助 "一项,观察到总体组(P = 0.0035)和放射技术人员(P = 0.048)的得分均有显著提高:小儿核磁共振成像镇静模拟有可能提高医护人员在核磁共振成像镇静方面的自我效能。我们的研究结果表明,这种培训在培养医护人员进行儿科磁共振成像镇静实践方面具有重要作用。
{"title":"The Impact of Simulation-Based Training on Self-Efficacy in Sedation for Pediatric Magnetic Resonance Imaging.","authors":"Yuto Arai, Kento Ohta, Go Yoshino, Tohru Okanishi, Yoshihiro Maegaki","doi":"10.33160/yam.2024.05.002","DOIUrl":"10.33160/yam.2024.05.002","url":null,"abstract":"<p><strong>Background: </strong>In Japan, approximately 35% of facilities experience sedation-related complications for pediatric magnetic resonance imaging (MRI), including severe complications such as respiratory and cardiac arrests. In the medical education field, simulation improves not only the quality of real emergency response but also health care workers' self-efficacy. Individuals with high self-efficacy are better prepared at handling diverse conditions. However, there is no research examining the impact of sedation simulation for pediatric MRI on the self-efficacy of health care workers. This study aimed to retrospectively investigate the impact of sedation simulation for pediatric MRI on the self-efficacy of health care workers in sedation.</p><p><strong>Methods: </strong>The study was conducted on August 18, 2023, and enrolled pediatricians, nurses, and radiological technologists. The impact of sedation simulation for pediatric MRI on the participants was analyzed using confidence scale scores and part of the Pediatric Resuscitation and Escalation of Care Self-Efficacy Scale (PRSES), before and after sedation simulation for pediatric MRI.</p><p><strong>Results: </strong>Eighteen participants (six pediatricians, six nurses, and six radiological technologists) were included in this study. Regarding confidence scale scores, a significant improvement was observed in the overall group (<i>P</i> = 0.002) and among the nurses (<i>P</i> = 0.0036). Regarding the item 'When confronted with a clinically deteriorating child, I know how to ask for assistance' of PRSES, a significant improvement was observed in the overall group (<i>P</i> = 0.0035) and among the radiological technologists (<i>P</i> = 0.048).</p><p><strong>Conclusion: </strong>There's a potential for sedation simulation for pediatric MRI to increase the self-efficacy of health care workers in MRI sedation. Our findings suggest that this training has a valuable role in preparing health care workers to practice sedation for pediatric MRI.</p>","PeriodicalId":23795,"journal":{"name":"Yonago acta medica","volume":"67 2","pages":"108-113"},"PeriodicalIF":1.0,"publicationDate":"2024-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11128076/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141158974","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-Term Outcomes for a Student with Severely Challenging Behavior in a Special Needs School for Intellectual Disabilities: A School Consultation Case Study. 智障特殊需求学校一名有严重挑战行为学生的长期结果:学校咨询案例研究》。
IF 1 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-04-17 eCollection Date: 2024-05-01 DOI: 10.33160/yam.2024.05.006
Masahiko Inoue

Self-injurious, stereotyped, and aggressive/destructive behaviors exhibited by individuals with intellectual disabilities and autism spectrum disorders are called challenging behaviors (CBs). Severe CBs often require long-term treatment involving psychosocial approaches based on behavioral interventions and/or medication. A boy with severe CB enrolled in a special needs school, with diagnoses of autism and intellectual disability, was the client of the study. This case report describes the long-term outcomes of eight years of continuous school consultation. The student's severe CB improved with environmental adjustments in the classroom, unified teacher involvement, instruction of leisure and communication skills, and medication. Long-term research on changes in CBs through school consultation is limited, and this case report provides important insights into the development of effective educational programs and curricula for severe CBs in school-aged children.

智障和自闭症谱系障碍患者表现出的自伤、刻板和攻击/破坏行为被称为挑战行为(CBs)。严重的挑战行为通常需要通过行为干预和/或药物治疗等社会心理方法进行长期治疗。本研究的对象是一名被诊断患有自闭症和智力障碍、在特殊学校就读的患有严重挑战行为的男孩。本病例报告描述了持续八年学校咨询的长期结果。通过课堂环境调整、教师的统一参与、休闲和沟通技巧指导以及药物治疗,该学生的严重自闭症得到了改善。有关通过学校咨询改变 CB 的长期研究非常有限,本案例报告为针对学龄儿童的严重 CB 制定有效的教育计划和课程提供了重要的启示。
{"title":"Long-Term Outcomes for a Student with Severely Challenging Behavior in a Special Needs School for Intellectual Disabilities: A School Consultation Case Study.","authors":"Masahiko Inoue","doi":"10.33160/yam.2024.05.006","DOIUrl":"10.33160/yam.2024.05.006","url":null,"abstract":"<p><p>Self-injurious, stereotyped, and aggressive/destructive behaviors exhibited by individuals with intellectual disabilities and autism spectrum disorders are called challenging behaviors (CBs). Severe CBs often require long-term treatment involving psychosocial approaches based on behavioral interventions and/or medication. A boy with severe CB enrolled in a special needs school, with diagnoses of autism and intellectual disability, was the client of the study. This case report describes the long-term outcomes of eight years of continuous school consultation. The student's severe CB improved with environmental adjustments in the classroom, unified teacher involvement, instruction of leisure and communication skills, and medication. Long-term research on changes in CBs through school consultation is limited, and this case report provides important insights into the development of effective educational programs and curricula for severe CBs in school-aged children.</p>","PeriodicalId":23795,"journal":{"name":"Yonago acta medica","volume":"67 2","pages":"163-168"},"PeriodicalIF":1.0,"publicationDate":"2024-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11128085/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141158844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Roles of Microglia in Neurodegenerative Diseases. 小胶质细胞在神经退行性疾病中的作用
IF 1 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-02-20 eCollection Date: 2024-02-01 DOI: 10.33160/yam.2024.02.001
Kazuhiro Nakaso

In recent years, microglia have attracted attention owing to their roles in various neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis. Microglia, which are brain-resident macrophages, not only act as immune cells but also perform other functions in the body. Interestingly, they exert contrasting effects on different neurodegenerative diseases. In addition to the previously reported M1 (toxic) and M2 (protective) types, microglia now also include disease-associated microglia owing to a more elaborate classification. Understanding this detailed classification is necessary to elucidate the association between microglia and neurodegenerative diseases. In this review, we discuss the diverse roles of microglia in neurodegenerative diseases and highlight their potential as therapeutic targets.

近年来,小胶质细胞因其在阿尔茨海默病、帕金森病和肌萎缩侧索硬化症等多种神经退行性疾病中的作用而备受关注。小胶质细胞是驻留在大脑中的巨噬细胞,它们不仅是免疫细胞,还在体内发挥其他功能。有趣的是,它们对不同的神经退行性疾病具有截然不同的作用。除了以前报道的 M1(毒性)和 M2(保护性)类型外,现在还包括与疾病相关的小胶质细胞,因为有了更详细的分类。要阐明小胶质细胞与神经退行性疾病之间的关联,就必须了解这种详细的分类。在这篇综述中,我们将讨论小胶质细胞在神经退行性疾病中的各种作用,并强调它们作为治疗靶点的潜力。
{"title":"Roles of Microglia in Neurodegenerative Diseases.","authors":"Kazuhiro Nakaso","doi":"10.33160/yam.2024.02.001","DOIUrl":"10.33160/yam.2024.02.001","url":null,"abstract":"<p><p>In recent years, microglia have attracted attention owing to their roles in various neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis. Microglia, which are brain-resident macrophages, not only act as immune cells but also perform other functions in the body. Interestingly, they exert contrasting effects on different neurodegenerative diseases. In addition to the previously reported M1 (toxic) and M2 (protective) types, microglia now also include disease-associated microglia owing to a more elaborate classification. Understanding this detailed classification is necessary to elucidate the association between microglia and neurodegenerative diseases. In this review, we discuss the diverse roles of microglia in neurodegenerative diseases and highlight their potential as therapeutic targets.</p>","PeriodicalId":23795,"journal":{"name":"Yonago acta medica","volume":"67 1","pages":"1-8"},"PeriodicalIF":1.0,"publicationDate":"2024-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10867232/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139913588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Case of Isolated Superior Mesenteric Artery Dissection Resulting in Recurrent Necrosis of the Small Intestine. 一例孤立性肠系膜上动脉离断导致小肠复发性坏死的病例。
IF 1 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-02-20 eCollection Date: 2024-02-01 DOI: 10.33160/yam.2024.02.009
Tomohiro Takahashi, Kengo Nishimura, Shoichi Urushibara, Akemi Iwamoto, Kazunori Suzuki, Hiroshi Nishie

Isolated superior mesenteric artery dissection (ISMAD) is a rare cause of acute abdominal conditions. Most cases of ISMAD have a favorable prognosis, and only a few cases of ISMAD-associated intestinal necrosis have been reported. A 75-year-old male was referred to our department because of abdominal pain and portal venous gas detected on imaging. Computed tomography suggested ileal necrosis, necessitating emergency surgery. Indocyanine green was used for blood flow assessment; however, no fluorescence was observed in the ileum proximal to the Bauhin valve, leading to the decision for ileocecal resection. On postoperative day 6, abdominal pain recurred when meals were resumed. As a surgical intervention for ISMAD, a bypass was created using the left great saphenous vein as a graft between the superior mesenteric artery and the right external iliac artery. This case highlights a rare occurrence where intestinal necrosis recurred due to ISMAD. We propose that in cases of ISMAD with concomitant intestinal necrosis, a more aggressive revascularization strategy for the dissected segment of the superior mesenteric artery may be required.

孤立性肠系膜上动脉夹层(ISMAD)是一种罕见的急腹症病因。大多数肠系膜上动脉夹层病例预后良好,仅有少数病例报道了肠系膜上动脉夹层导致的肠坏死。一名 75 岁的男性因腹痛和影像学检查发现门静脉积气而被转诊至我科。计算机断层扫描提示回肠坏死,必须进行急诊手术。吲哚菁绿用于血流评估,但在鲍欣瓣膜近端回肠未观察到荧光,因此决定进行回盲部切除术。术后第 6 天,恢复进食后腹痛再次出现。作为对 ISMAD 的手术干预,使用左大隐静脉作为肠系膜上动脉和右髂外动脉之间的移植物,建立了一条旁路。本病例凸显了因 ISMAD 导致肠坏死复发的罕见情况。我们建议,对于同时伴有肠坏死的 ISMAD 病例,可能需要对肠系膜上动脉剥离段采取更积极的血管重建策略。
{"title":"A Case of Isolated Superior Mesenteric Artery Dissection Resulting in Recurrent Necrosis of the Small Intestine.","authors":"Tomohiro Takahashi, Kengo Nishimura, Shoichi Urushibara, Akemi Iwamoto, Kazunori Suzuki, Hiroshi Nishie","doi":"10.33160/yam.2024.02.009","DOIUrl":"10.33160/yam.2024.02.009","url":null,"abstract":"<p><p>Isolated superior mesenteric artery dissection (ISMAD) is a rare cause of acute abdominal conditions. Most cases of ISMAD have a favorable prognosis, and only a few cases of ISMAD-associated intestinal necrosis have been reported. A 75-year-old male was referred to our department because of abdominal pain and portal venous gas detected on imaging. Computed tomography suggested ileal necrosis, necessitating emergency surgery. Indocyanine green was used for blood flow assessment; however, no fluorescence was observed in the ileum proximal to the Bauhin valve, leading to the decision for ileocecal resection. On postoperative day 6, abdominal pain recurred when meals were resumed. As a surgical intervention for ISMAD, a bypass was created using the left great saphenous vein as a graft between the superior mesenteric artery and the right external iliac artery. This case highlights a rare occurrence where intestinal necrosis recurred due to ISMAD. We propose that in cases of ISMAD with concomitant intestinal necrosis, a more aggressive revascularization strategy for the dissected segment of the superior mesenteric artery may be required.</p>","PeriodicalId":23795,"journal":{"name":"Yonago acta medica","volume":"67 1","pages":"68-74"},"PeriodicalIF":1.0,"publicationDate":"2024-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10867238/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139913587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mechanism Underlying Conflicting Drug-Drug Interaction Between Aprepitant and Voriconazole via Cytochrome P450 3A4-Mediated Metabolism. 阿瑞匹坦与伏立康唑通过细胞色素 P450 3A4 介导的代谢产生的药物间相互作用相互矛盾的机制。
IF 1 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-01-24 eCollection Date: 2024-02-01 DOI: 10.33160/yam.2024.02.004
Masako Ishida, Takeshi Kumagai, Tatsuro Yamamoto, Hiroyuki Suzuki, Kuniaki Moriki, Masachika Fujiyoshi, Kiyoshi Nagata, Miki Shimada

Background: Voriconazole is an antifungal drug for which therapeutic monitoring is recommended to prevent side effects. Temporary administration of the antiemetic drug fosaprepitant remarkably decreases the plasma concentration of voriconazole from the therapeutic range. The ratio of the major metabolite voriconazole N-oxide to voriconazole exceeded that at any other time for a patient who started chemotherapy during voriconazole therapy. We attributed this unpredictable result to cytochrome P450 3A4 induced by aprepitant that was converted from fosaprepitant in vivo.

Methods: Concentrations of voriconazole and voriconazole N-oxide were measured using liquid chromatography-mass spectrometry/mass spectrometry in primary human hepatocytes after incubation with aprepitant. Aprepitant suppressed voriconazole N-oxide formation within 24 h, followed by a continuous increase. Levels of drug-metabolizing cytochrome P450 mRNA were measured using real-time PCR in primary human hepatocytes incubated with aprepitant.

Results: Cytochrome P450 3A4 and 2C9 mRNA levels increased ~4- and 2-fold, respectively, over time. Cytochrome P450 3A4 induction was confirmed using reporter assays. We also assessed L-755446, a major metabolite of aprepitant that lacks a triazole ring. Both compounds dose-dependently increased reporter activity; however, induction by L-755446 was stronger than that by aprepitant.

Conclusion: These results indicate that aprepitant initially inhibited voriconazole metabolism via its triazole ring and increased cytochrome P450 3A4 induction following L-755446 formation. The decrease in plasma voriconazole concentration 7 days after fosaprepitant administration was mainly attributed to cytochrome P450 3A4 induction by L-755446.

背景:伏立康唑是一种抗真菌药物,建议对其进行治疗监测以防止副作用。临时服用止吐药福沙匹坦(fosaprepitant)会显著降低伏立康唑的血浆浓度,使其超出治疗范围。一名患者在接受伏立康唑治疗期间开始接受化疗,其主要代谢产物伏立康唑 N-氧化物与伏立康唑的比率超过了其他任何时候的比率。我们将这一不可预知的结果归因于体内由福沙匹坦转化而来的阿普瑞坦诱导的细胞色素 P450 3A4:方法:使用液相色谱-质谱法/质谱法测量了与阿普瑞坦培养后的原代人类肝细胞中伏立康唑和伏立康唑N-氧化物的浓度。阿普瑞坦在 24 小时内抑制了伏立康唑 N-氧化物的形成,随后出现持续增长。用实时 PCR 法测量了与阿瑞匹坦培养的原代人肝细胞中药物代谢细胞色素 P450 mRNA 的水平:结果:随着时间的推移,细胞色素 P450 3A4 和 2C9 mRNA 水平分别增加了约 4 倍和 2 倍。细胞色素 P450 3A4 诱导作用已通过报告实验得到证实。我们还评估了缺乏三唑环的阿瑞匹坦主要代谢物 L-755446。这两种化合物都能剂量依赖性地增加报告活性;然而,L-755446的诱导作用强于阿瑞匹坦:这些结果表明,阿瑞匹坦最初通过其三唑环抑制伏立康唑的代谢,并在 L-755446 形成后增加细胞色素 P450 3A4 诱导。服用福沙匹坦 7 天后血浆中伏立康唑浓度的降低主要是由于 L-755446 诱导细胞色素 P450 3A4 的作用。
{"title":"Mechanism Underlying Conflicting Drug-Drug Interaction Between Aprepitant and Voriconazole via Cytochrome P450 3A4-Mediated Metabolism.","authors":"Masako Ishida, Takeshi Kumagai, Tatsuro Yamamoto, Hiroyuki Suzuki, Kuniaki Moriki, Masachika Fujiyoshi, Kiyoshi Nagata, Miki Shimada","doi":"10.33160/yam.2024.02.004","DOIUrl":"10.33160/yam.2024.02.004","url":null,"abstract":"<p><strong>Background: </strong>Voriconazole is an antifungal drug for which therapeutic monitoring is recommended to prevent side effects. Temporary administration of the antiemetic drug fosaprepitant remarkably decreases the plasma concentration of voriconazole from the therapeutic range. The ratio of the major metabolite voriconazole <i>N</i>-oxide to voriconazole exceeded that at any other time for a patient who started chemotherapy during voriconazole therapy. We attributed this unpredictable result to cytochrome P450 3A4 induced by aprepitant that was converted from fosaprepitant in vivo.</p><p><strong>Methods: </strong>Concentrations of voriconazole and voriconazole <i>N</i>-oxide were measured using liquid chromatography-mass spectrometry/mass spectrometry in primary human hepatocytes after incubation with aprepitant. Aprepitant suppressed voriconazole <i>N</i>-oxide formation within 24 h, followed by a continuous increase. Levels of drug-metabolizing cytochrome P450 mRNA were measured using real-time PCR in primary human hepatocytes incubated with aprepitant.</p><p><strong>Results: </strong>Cytochrome P450 3A4 and 2C9 mRNA levels increased ~4- and 2-fold, respectively, over time. Cytochrome P450 3A4 induction was confirmed using reporter assays. We also assessed L-755446, a major metabolite of aprepitant that lacks a triazole ring. Both compounds dose-dependently increased reporter activity; however, induction by L-755446 was stronger than that by aprepitant.</p><p><strong>Conclusion: </strong>These results indicate that aprepitant initially inhibited voriconazole metabolism via its triazole ring and increased cytochrome P450 3A4 induction following L-755446 formation. The decrease in plasma voriconazole concentration 7 days after fosaprepitant administration was mainly attributed to cytochrome P450 3A4 induction by L-755446.</p>","PeriodicalId":23795,"journal":{"name":"Yonago acta medica","volume":"67 1","pages":"31-40"},"PeriodicalIF":1.0,"publicationDate":"2024-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10867237/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139901125","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationship Between Clinical Nursing Competence and Work Environment by Career Stage for Nurses with 1-10 Years of Clinical Experience. 具有 1-10 年临床经验的护士在不同职业阶段的临床护理能力与工作环境之间的关系。
IF 1 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-01-20 eCollection Date: 2024-02-01 DOI: 10.33160/yam.2024.02.002
Miho Saiga, Yoko Yamamoto, Reiko Okuda, Mika Fukada

Background: Clinical nursing competence includes ethics, cooperation with other professionals, and management, in addition to nursing abilities and responding per situation. Therefore, it may vary depending on one's experience and the work environment. However, there is a lack of studies exploring the competence for different experience levels. Therefore, this study aimed to clarify the association between clinical nursing competence and the work environment by experience groups.

Methods: Anonymous self-administered questionnaire surveys were conducted on 717 nurses in regional core hospitals from December 2017 to March 2018. Clinical nursing competence was measured using the Clinical Nursing Competence Self-Assessment Scale (CNCSS). Association of CNCSS with experience and work environment was examined.

Results: Responses from 231 nurses with 1-10 years of experience were analyzed. Compared with those in the 2-year experience group, those in the 3-5- and 6-10-year experience groups assessed their "planned development of nursing care" and "assessment of care" competencies to be higher. Additionally, compared with those in the 2-year experience group, those in the 6-10-year experience group assessed their "clinical judgment" and "care coordination" competencies to be higher. Nurses with 1 year of experience showed significant positive correlations between clinical nursing competence and "good interpersonal relationship," "clarity about the organization's vision," and "ease of taking time off"; and those with 6-10 years of experience showed significant positive correlations between clinical nursing competence and "support from superiors and senior coworkers" and "established and easily accessible support system for taking time off for childcare and caregiving."

Conclusion: The relationship between clinical nursing competence and the work environment differed according to years of experience. Interventions to improve clinical nursing competence should be developed for each experience group considering the associations.

背景:临床护理能力除了包括护理能力和对不同情况的反应外,还包括职业道德、与其他专业人员的合作以及管理。因此,护理能力会因个人经验和工作环境的不同而有所差异。然而,目前还缺乏针对不同经验水平的能力的研究。因此,本研究旨在按经验组别阐明临床护理能力与工作环境之间的关联:2017年12月至2018年3月,对地区核心医院的717名护士进行了匿名自填式问卷调查。临床护理能力采用临床护理能力自评量表(CNCSS)进行测量。研究了CNCSS与工作经验和工作环境的关系:对 231 名工作经验为 1-10 年的护士的回答进行了分析。与工作经验为 2 年的护士相比,工作经验为 3-5 年和 6-10 年的护士对其 "有计划地开展护理工作 "和 "评估护理工作 "能力的评价更高。此外,与 2 年经验组的护士相比,6-10 年经验组的护士对其 "临床判断 "和 "护理协调 "能力的评价更高。工作经验为 1 年的护士的临床护理能力与 "良好的人际关系"、"对组织愿景的清晰认识 "和 "请假的便利性 "之间呈显著正相关;工作经验为 6-10 年的护士的临床护理能力与 "来自上级和资深同事的支持 "和 "为照顾子女和护理请假而建立的、易于获得的支持系统 "之间呈显著正相关:临床护理能力与工作环境之间的关系因工作年限而异。考虑到这些关联,应针对不同年资组别制定干预措施,以提高临床护理能力。
{"title":"Relationship Between Clinical Nursing Competence and Work Environment by Career Stage for Nurses with 1-10 Years of Clinical Experience.","authors":"Miho Saiga, Yoko Yamamoto, Reiko Okuda, Mika Fukada","doi":"10.33160/yam.2024.02.002","DOIUrl":"10.33160/yam.2024.02.002","url":null,"abstract":"<p><strong>Background: </strong>Clinical nursing competence includes ethics, cooperation with other professionals, and management, in addition to nursing abilities and responding per situation. Therefore, it may vary depending on one's experience and the work environment. However, there is a lack of studies exploring the competence for different experience levels. Therefore, this study aimed to clarify the association between clinical nursing competence and the work environment by experience groups.</p><p><strong>Methods: </strong>Anonymous self-administered questionnaire surveys were conducted on 717 nurses in regional core hospitals from December 2017 to March 2018. Clinical nursing competence was measured using the Clinical Nursing Competence Self-Assessment Scale (CNCSS). Association of CNCSS with experience and work environment was examined.</p><p><strong>Results: </strong>Responses from 231 nurses with 1-10 years of experience were analyzed. Compared with those in the 2-year experience group, those in the 3-5- and 6-10-year experience groups assessed their \"planned development of nursing care\" and \"assessment of care\" competencies to be higher. Additionally, compared with those in the 2-year experience group, those in the 6-10-year experience group assessed their \"clinical judgment\" and \"care coordination\" competencies to be higher. Nurses with 1 year of experience showed significant positive correlations between clinical nursing competence and \"good interpersonal relationship,\" \"clarity about the organization's vision,\" and \"ease of taking time off\"; and those with 6-10 years of experience showed significant positive correlations between clinical nursing competence and \"support from superiors and senior coworkers\" and \"established and easily accessible support system for taking time off for childcare and caregiving.\"</p><p><strong>Conclusion: </strong>The relationship between clinical nursing competence and the work environment differed according to years of experience. Interventions to improve clinical nursing competence should be developed for each experience group considering the associations.</p>","PeriodicalId":23795,"journal":{"name":"Yonago acta medica","volume":"67 1","pages":"9-21"},"PeriodicalIF":1.0,"publicationDate":"2024-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10867233/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139900522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of Subtraction Computed Tomography Arteriography During Preoperative Embolization in Spinal Tumors. 脊柱肿瘤术前栓塞术中减影计算机断层扫描动脉造影的疗效
IF 1 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-01-17 eCollection Date: 2024-02-01 DOI: 10.33160/yam.2024.02.007
Jun Makishima, Shuichi Yamamoto, Shinsaku Yata, Shohei Takasugi, Yuji Kamata, Shinji Tanishima, Shinya Fujii

Background: This study aimed to evaluate the efficacy of subtraction computed tomography arteriography (s-CTA) during preoperative embolization in spinal tumors.

Methods: The study analyzed 17 vertebrae in 13 patients who underwent preoperative embolization before spinal fixation surgery for malignant spinal tumors to decrease blood loss at our hospital from 2019 to 2021. Their ages ranged from 56 to 88 years (average, 73.5 years). Metastatic bone tumors were most common, including five cases originating as lung carcinomas and three as renal cancers. After digital subtraction angiography of selected tumor-feeding arteries and non-subtraction CTA (ns-CTA) were performed, s-CTA was conducted using data obtained from both procedures. A clarity score of the boundary between the normal bone and tumor was derived for each patient, which was then classified into four grades (good, 3 points; fair, 2 points; faint, 1 point; poor, 0 points) by two experienced radiologists, followed by a comparison between the s-CTA and ns-CTA groups using the Wilcoxon signed-rank test.

Results: Clarity scores were significantly higher in the s-CTA group than in the ns-CTA group (P < 0.001). The agreement of Cohen's coefficients between the two radiologists was κ = 0.724 in s-CTA scoring and κ = 0.622 in ns-CTA scoring, which were moderately matched. Seven arteries were not embolized due to insufficient tumor contrast enhancement and their poor relation to the surgical invasion zone. No complications were observed during or after embolization.

Conclusion: S-CTA successfully distinguished between tumor and normal bone and may help avoid unnecessary embolization.

背景:本研究旨在评估脊柱肿瘤术前栓塞时减影计算机断层扫描动脉造影(s-CTA)的疗效:本研究旨在评估脊柱肿瘤术前栓塞期间减影计算机断层扫描动脉造影(s-CTA)的疗效:该研究分析了 2019 年至 2021 年在我院接受脊柱固定手术治疗恶性脊柱肿瘤的 13 例患者的 17 个椎体,这些患者在脊柱固定手术前接受了术前栓塞以减少失血。他们的年龄从 56 岁到 88 岁不等(平均 73.5 岁)。转移性骨肿瘤最为常见,其中5例为肺癌,3例为肾癌。在对选定的肿瘤供血动脉进行数字减影血管造影和非减影 CTA(ns-CTA)检查后,利用这两种检查获得的数据进行了 s-CTA。由两名经验丰富的放射科医生对每位患者的正常骨骼和肿瘤之间的边界进行清晰度评分,并将其分为四个等级(良好,3 分;尚可,2 分;模糊,1 分;差,0 分),然后使用 Wilcoxon 符号秩检验对 s-CTA 组和 ns-CTA 组进行比较:结果:s-CTA 组的清晰度评分明显高于 ns-CTA 组(P < 0.001)。两位放射科医生的 Cohen's 系数一致,s-CTA 评分为 κ = 0.724,ns-CTA 评分为 κ = 0.622,属于中等匹配。由于肿瘤对比度增强不足以及与手术侵犯区关系不佳,有七条动脉没有栓塞。栓塞过程中和栓塞后均未见并发症:结论:S-CTA 能成功区分肿瘤和正常骨,有助于避免不必要的栓塞。
{"title":"Efficacy of Subtraction Computed Tomography Arteriography During Preoperative Embolization in Spinal Tumors.","authors":"Jun Makishima, Shuichi Yamamoto, Shinsaku Yata, Shohei Takasugi, Yuji Kamata, Shinji Tanishima, Shinya Fujii","doi":"10.33160/yam.2024.02.007","DOIUrl":"10.33160/yam.2024.02.007","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to evaluate the efficacy of subtraction computed tomography arteriography (s-CTA) during preoperative embolization in spinal tumors.</p><p><strong>Methods: </strong>The study analyzed 17 vertebrae in 13 patients who underwent preoperative embolization before spinal fixation surgery for malignant spinal tumors to decrease blood loss at our hospital from 2019 to 2021. Their ages ranged from 56 to 88 years (average, 73.5 years). Metastatic bone tumors were most common, including five cases originating as lung carcinomas and three as renal cancers. After digital subtraction angiography of selected tumor-feeding arteries and non-subtraction CTA (ns-CTA) were performed, s-CTA was conducted using data obtained from both procedures. A clarity score of the boundary between the normal bone and tumor was derived for each patient, which was then classified into four grades (good, 3 points; fair, 2 points; faint, 1 point; poor, 0 points) by two experienced radiologists, followed by a comparison between the s-CTA and ns-CTA groups using the Wilcoxon signed-rank test.</p><p><strong>Results: </strong>Clarity scores were significantly higher in the s-CTA group than in the ns-CTA group (<i>P</i> < 0.001). The agreement of Cohen's coefficients between the two radiologists was κ = 0.724 in s-CTA scoring and κ = 0.622 in ns-CTA scoring, which were moderately matched. Seven arteries were not embolized due to insufficient tumor contrast enhancement and their poor relation to the surgical invasion zone. No complications were observed during or after embolization.</p><p><strong>Conclusion: </strong>S-CTA successfully distinguished between tumor and normal bone and may help avoid unnecessary embolization.</p>","PeriodicalId":23795,"journal":{"name":"Yonago acta medica","volume":"67 1","pages":"61-67"},"PeriodicalIF":1.0,"publicationDate":"2024-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10867234/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139900518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Yonago acta medica
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1